Albuterol Inhaler Clinical Trials

• Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
  ClinicalTrials.gov Identifier: NCT00530062 - Recruiting
  Asthma
  
• Comparative effectiveness of a breath-operated albuterol inhaler in asthma patients with poor inhaler technique
  ClinicalTrials.gov Identifier: NCT00054964 - Completed
  Asthma
  
• Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
  ClinicalTrials.gov Identifier: NCT00162487 - Recruiting
  Hyperkalemia; Chronic Renal Failure
  
• Genetic Determinants of the Bronchodilatation Effect of Albuterol Ex-Vivo.
  ClinicalTrials.gov Identifier: NCT00162422 - Recruiting
  Asthma
  
• Trial of Epinephrine and Albuterol in Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00114478 - Active, not recruiting
  Bronchiolitis
  
• Treatment of Multiple Sclerosis with Copaxone and Albuterol
  ClinicalTrials.gov Identifier: NCT00039988 - Active, not recruiting
  Autoimmune Diseases; Multiple Sclerosis
  
• Randomized Study of Albuterol in Patients with Facioscapulohumeral Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00004685 - Active, not recruiting
  Muscular Dystrophy, Facioscapulohumeral
  
• Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
  ClinicalTrials.gov Identifier: NCT00144846 - Recruiting
  acute wheezing obstructive airways disease
  
• A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control
  ClinicalTrials.gov Identifier: NCT00385359 - Recruiting
  Asthma
  
• Drug Study of Albuterol to Treat Acute Lung Injury
  ClinicalTrials.gov Identifier: NCT00434993 - Recruiting
  Respiratory Distress Syndrome, Adult
  
• Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-MDI In Pediatric Asthmatics
  ClinicalTrials.gov Identifier: NCT00577655 - Recruiting
  Asthma
  
• Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation
  ClinicalTrials.gov Identifier: NCT00410150 - Recruiting
  Status Asthmaticus
  
• Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
  ClinicalTrials.gov Identifier: NCT00096616 - Completed
  Asthma
  
• DESOLO – SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
  ClinicalTrials.gov Identifier: NCT00252863 - Active, not recruiting
  Asthma
  
• Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00394199 - Active, not recruiting
  Asthma
  
• The Effect of Nebulized Albuterol on Donor Oxygenation
  ClinicalTrials.gov Identifier: NCT00310401 - Recruiting
  Brain Death; Organ Donor; Pulmonary Edema
  
• Genetic Influences of Albuterol Response In Children With Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00570297 - Recruiting
  Bronchiolitis
  
• Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
  ClinicalTrials.gov Identifier: NCT00027391 - Completed
  Muscular Dystrophies
  
• Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI
  ClinicalTrials.gov Identifier: NCT00565591 - Recruiting
  Allergic Asthma
  
• MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults
  ClinicalTrials.gov Identifier: NCT00242411 - Active, not recruiting
  Asthma
  
• New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00394121 - Active, not recruiting
  Asthma
  
• Genetic Determinants of the Response to Salbutamol Among Asthma Patients
  ClinicalTrials.gov Identifier: NCT00162396 - Recruiting
  Asthma
  
• NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler
  ClinicalTrials.gov Identifier: NCT00557297 - Recruiting
  Asthma
  
• Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
  ClinicalTrials.gov Identifier: NCT00476099 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418AM4)
  ClinicalTrials.gov Identifier: NCT00394355 - Recruiting
  Asthma
  
• An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
  ClinicalTrials.gov Identifier: NCT00528996 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
  ClinicalTrials.gov Identifier: NCT00385593 - Recruiting
  Asthma, Bronchial
  
• Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00393991 - Recruiting
  Asthma
  
• Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler
  ClinicalTrials.gov Identifier: NCT00524641 - Recruiting
  Asthma
  
• Bronchodilatory Efficacy of a Single Dose QMF149 Via a Multiple-Dose Dry Powder Inhaler (MDDPI) in Adult Asthma Patients
  ClinicalTrials.gov Identifier: NCT00556673 - Recruiting
  Asthma
  
• STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00252824 - Recruiting
  Asthma
  
• New Combination Inhaler (Flutiform HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
  ClinicalTrials.gov Identifier: NCT00393952 - Recruiting
  Asthma
  
• Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler
  ClinicalTrials.gov Identifier: NCT00426920 - Not yet recruiting
  Diabetes Mellitus
  
• A multi-centered study of the long-term effect of salmeterol and albuterol in cystic fibrosis
  ClinicalTrials.gov Identifier: NCT00005110 - Suspended
  Cystic Fibrosis
  
• Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00538057 - Not yet recruiting
  Healthy Volunteers
  
• Long-Term Safety Study Of Inhaled Insulin (CP-464,005, CP-464,005/Inhaler) In Japanese Patients With Type1 or Type2 Diabetes
  ClinicalTrials.gov Identifier: NCT00527397 - Recruiting
  Diabetes Mellitus Type 2; Diabetes Mellitus Type 1
  
• A Randomised Open Label, Six Way, Cross-Over Scintigraphic Evaluation of the Effect of Inspiratory Flow Rate on Lung and Oropharyngeal Deposition with the Respimat® Inhaler Vs. a Metered Dose Inhaler (HFA-MDI) Using Berodual® in Patients with Ch
  ClinicalTrials.gov Identifier: NCT00153075 - Completed
  Pulmonary Disease, Chronic Obstructive; Asthma
  
• Bronchodilatation Effects of a Small Volume Spacer Used With a Metered-Dose Inhaler
  ClinicalTrials.gov Identifier: NCT00465413 - Completed
  Asthma
  
• Chronic-Dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics
  ClinicalTrials.gov Identifier: NCT00308685 - Completed
  Asthma
  
• Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol
  ClinicalTrials.gov Identifier: NCT00325767 - Completed
  Mucociliary Clearance
  
• Study of Daily Dosing with Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects with Asthma
  ClinicalTrials.gov Identifier: NCT00073814 - Completed
  Asthma
  
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older with Asthma
  ClinicalTrials.gov Identifier: NCT00073827 - Completed
  Asthma
  
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older with Asthma
  ClinicalTrials.gov Identifier: NCT00073840 - Completed
  Asthma
  
• Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older with Asthma
  ClinicalTrials.gov Identifier: NCT00064389 - Completed
  Asthma
  
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
  ClinicalTrials.gov Identifier: NCT00239447 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
  ClinicalTrials.gov Identifier: NCT00281567 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
  ClinicalTrials.gov Identifier: NCT00235911 - Completed
  Asthma
  
• Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
  ClinicalTrials.gov Identifier: NCT00319306 - Completed
  Asthma
  
• As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00382889 - Completed
  Asthma
  
• Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00476268 - Completed
  Asthma
  
• SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults
  ClinicalTrials.gov Identifier: NCT00259792 - Completed
  Asthma
  
• Asthma Clinical Research Network (ACRN)
  ClinicalTrials.gov Identifier: NCT00000577 - Completed
  Asthma; Lung Diseases
  
• Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).
  ClinicalTrials.gov Identifier: NCT00404261 - Completed
  Asthma; COPD
  
• Treatment for Smoking
  ClinicalTrials.gov Identifier: NCT00108342 - Completed
  Smoking
  
• SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00290264 - Completed
  Asthma
  
• Phase III Randomized Study of Nicotine Inhaler Versus Bupropion Versus Nicotine Inhaler Plus Bupropion for Smoking Cessation and Prevention of Relapse in Participants Who Currently Smoke
  ClinicalTrials.gov Identifier: NCT00033592 - Completed
  Small Cell Lung Cancer; prevention of lung cancer; Non-small cell lung cancer
  
• Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00403637 - Completed
  Asthma
  
• Non-Nicotine Agents for Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00108537 - Completed
  Tobacco Use Disorder
  
• Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00396604 - Completed
  Pulmonary Disease, Chronic Obstructive; COPD; Lung Diseases, Obstructive
  
• Efficacy Study of Single-Dose Levalbuterol Tartrate Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI) Versus Placebo in Prevention of Exercise-Induced Bronchospasm (EIB) in Subjects 18 Years of Age and Older With Exercise-Induced Bronchospasm
  ClinicalTrials.gov Identifier: NCT00268723 - Completed
  Exercise-Induced Bronchospasm
  
• A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00239434 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study
  ClinicalTrials.gov Identifier: NCT00361452 - Terminated
  Rsv Bronchiolitis
  
• A Randomized, Multiple-Dose, Double-Blind, Crossover Study to Compare the Efficacy and Safety of 200 µg and 400 µg of BEA 2180 BR to Tiotropium 5 µg and Placebo When Each is Delivered by the Respimat® Inhaler in Patients with Chronic O
  ClinicalTrials.gov Identifier: NCT00128440 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• A Randomized, Multiple-Dose, Double-Blind, Placebo- and Active Controlled, Parallel Group Efficacy and Safety Study to Determine the Optimum Dose of BEA 2180 BR Delivered by the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00122434 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Evaluation of the Respimat® Inhaler Vs. a HFA MDI Using Berodual® in Patients With COPD With Poor MDI Technique.
  ClinicalTrials.gov Identifier: NCT00267917 - Completed
  Pulmonary Disease, Chronic Obstructive; Asthma
  
• Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking
  ClinicalTrials.gov Identifier: NCT00021138 - Completed
  Small Cell Lung Cancer; prevention of lung cancer; prevention of esophageal cancer; Non-small cell lung cancer; prevention of head and neck cancer; ...